Navigenics, 23andMe Respond To DTC Genetics Opinion Paper

In an open letter appearing on the companies' web sites, Navigenics and 23andMe addressed criticisms leveled at direct-to-consumer test results in an opinion paper in Nature last month.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories